Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAIC vs Capecitabine as Adjuvant Therapy for Biliary Tract Malignancies
NCT07916844Phase 3Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil in biliary tract cancer (BTC). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
oxaliplatinfluorouracil
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT07916844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07916844.